ArticleJournal of translational medicine2011
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma.
Sheng-Hua Chu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it